Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAL Intensification
NCT02100475Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2014
- Primary completion
- Apr 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of insulin degludec + liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2014; status: completed.
02
Drugs
insulin degludec + liraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02100475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02100475.